跳至主要内容
临床试验/TCTR20211121002
TCTR20211121002已完成不适用

rine Liver-Type Fatty-Acid Binding Protein (L-FABP) and/or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis of Acute Kidney Injury in Cirrhotic Patients

Ratchadapisek Sompoch Funding, Chulalongkorn University0 个研究点目标入组 139 人开始时间: 2021年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
139

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Known diagnosis of cirrhosis
  • 2. Presence of risk of acute kidney injury, including gastrointestinal bleeding, bacterial infection, diarrhea, vomiting, poor intake, large-volume paracentesis, excessive diuretics usage, taking nephrotoxic drugs, and acute decompensation

排除标准

  • 1. Prior liver or kidney transplantation
  • 2. End-stage renal disease with renal replacement therapy at the time of enrollment
  • 3. Acute interstitial nephritis
  • 4. Acute glomerulonephritis
  • 5. Post-renal acute kidney injury
  • 4. Current use of immunosuppressive agents other than treatment of severe alcoholic hepatitis
  • 5. Severe extrahepatic disease
  • 6. Pregnancy

研究者

发起方
Ratchadapisek Sompoch Funding, Chulalongkorn University

相似试验